🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New research by the team of Prof. Charlotte Scott (VIB) reveals that a specific activation state of one of the immune cell types in our livers is required for tissue repair following injury. 🔗 flanders.bio/news/specific-…

Researchers at VIB-KU Leuven Center for Microbiology and VIB-KU Leuven Center for Brain & Disease Research revealed the relationship between #ProteinAggregation and #BacterialDormancy, states during which bacteria are not susceptible to #antibiotics. 🧫 flanders.bio/news/new-study…

🚨 Early bird registration for #KfG2025 closes 15 Feb 2025, 23:59 CEST! Join our top life sciences event to connect, learn, and discover the future of #biotech, #pharma, #medtech & #healthtech 🌱 💸 Don’t miss the best rate — register now 👉 knowledgeforgrowth.be #lifesciences

Allegro Biotech has been awarded the prestigious #CompanionAnimalsPrize at the #AnimalHealthEurope2025 Conference in London. 🏆 🔗 flanders.bio/news/allegro-w…

Augustine Therapeutics has appointed Gerhard Koenig, PhD, as Chief Executive Officer. 🔗 flanders.bio/news/augustine…

Prof. Stein Aerts and his team at VIB.AI and VIB-KU Leuven Center for Brain & Disease Research explored how genetic switches, controlling gene activity, define brain cell types across species. Their study was published in Science. 🔗 flanders.bio/news/scientist…

Big news for #RRP patients! Precigen’s biologics license application (#BLA) for PRGN-2012, a groundbreaking AdenoVerse® #genetherapy, has been accepted by the FDA. With priority review granted, the FDA has set a target action date of Aug 27, 2025. 🫁 flanders.bio/news/fda-grant…

4Tissue has completed a €1.5M funding round to advance its bioresorbable #hydrogel technology. The company is also excited to welcome Dr. Katleen Verleysen as independent chair of the board. 🚀flanders.bio/news/4tissue-s…

Positive interim results in @Agomab_’s ongoing #STENOVA Phase 2a clinical trial for the potential treatment of Fibrostenosing Crohn’s Disease (#FSCD)! 🔬 flanders.bio/news/agomab-an…

Field trials with one of Biotalys’ lead candidates for #BioFun6 highlight the increased potency of the new candidate against #Botrytis and #PowderyMildew in fruits and vegetables. 🍇 flanders.bio/news/biotalys-…

New research, led by researchers at the VIB-UGent Center for Plant Systems Biology, provides a comprehensive understanding of how #brassinosteroids influence development at the cellular level. 🌿 flanders.bio/news/new-insig…

By reprogramming the metabolism of T cells, scientists at the CCB_VIB_KUL and their collaborators demonstrated a remarkable ability to boost the immune system's fight against cancer. 🦠 flanders.bio/news/reprogram…

Augustine Therapeutics successfully completed its Series A financing round, raising a total of EUR 77.7 million. The proceeds will be used to advance Augustine’s lead candidate, AGT-100216. 🔗 flanders.bio/news/augustine…

At the upcoming shareholders’ meeting, Biotalys will be appointing Toni Bucci as independent director to its Board of Directors. 👩🏽‍🔬 flanders.bio/news/biotalys-…